Provided are methods comprising presenting a sensory environment to an individual experiencing the effects of a psychoactive agent, monitoring the neural status, the physiological status, or both, of the individual, and presenting a modified sensory environment to the individual based on the monitoring. In certain embodiments, the agent is a psychedelic agent. According to some embodiments, presenting a sensory environment to the individual comprises presenting to the individual a visual stimulus, an auditory stimulus, a tactile stimulus, an olfactory stimulus, or any combination thereof. In certain embodiments, presenting a modified sensory environment to the individual comprises presenting a customized sensory environment to the individual in real-time based on the monitoring. In some embodiments, the individual is suffering from a mental health condition selected from depression, anxiety, post-traumatic stress disorder (PTSD), addiction, and any combination thereof. Systems that find use in practicing the methods of the present disclosure are also provided.

Provided are methods comprising presenting a sensory environment to an individual experiencing the effects of a psychoactive agent, monitoring the neural status, the physiological status, or both, of the individual, and presenting a modified sensory environment to the individual based on the monitoring. In certain embodiments, the agent is a psychedelic agent. According to some embodiments, presenting a sensory environment to the individual comprises presenting to the individual a visual stimulus, an auditory stimulus, a tactile stimulus, an olfactory stimulus, or any combination thereof. In certain embodiments, presenting a modified sensory environment to the individual comprises presenting a customized sensory environment to the individual in real-time based on the monitoring. In some embodiments, the individual is suffering from a mental health condition selected from depression, anxiety, post-traumatic stress disorder (PTSD), addiction, and any combination thereof. Systems that find use in practicing the methods of the present disclosure are also provided.

A controllable window of time is provided for waking a user from sleep. A system uses this window to variably control the acquisition of physiological data from a device such as a wearable monitor, such as by initiating data acquisition at the beginning of the window, and the acquired data can be used in turn to control when, during the window, an active alarm to the user might be provided. Using this technique, data acquisition from a physiological monitoring device or the like can be increased around the onset of the window to more accurately calculate a suitable waking time for the user within the window. This advantageously avoids the need for continuous, high-frequency data communications during long intervals of sleep, and focuses data transmission, related communications, and computing resources on those intervals when up-to-date data might be most useful for optimizing the user's wake up experience.

The present application discloses and describes neurostimulation systems and methods that include, among other features, (i) neural stimulation through audio with dynamic modulation characteristics, (ii) audio content serving and creation based on modulation characteristics, (iii) extending audio tracks while avoiding audio discontinuities, and (iv) non-auditory neurostimulation and methods, including non-auditory neurostimulation for anesthesia recovery.

The present application discloses and describes neurostimulation systems and methods that include, among other features, (i) neural stimulation through audio with dynamic modulation characteristics, (ii) audio content serving and creation based on modulation characteristics, (iii) extending audio tracks while avoiding audio discontinuities, and (iv) non-auditory neurostimulation and methods, including non-auditory neurostimulation for anesthesia recovery.

A method of determining a duration of safe apnoea. Information is obtained relating to a respiratory indicator, and a duration of safe apnoea is determined from the obtained information. A respiratory therapy system has one or more patient interfaces. A processor is configured to determine a duration of safe apnoea based on obtained information relating to a respiratory indicator.

Systems and methods for partial aortic occlusion are provided. The system may include a catheter having an expandable aortic blood flow regulation device disposed on the distal end of the catheter for placement within an aorta of a patient, and a catheter controller unit that causes the device to expand and contract to restrict blood flow through the aorta. The system also may include sensors for measuring blood pressure distal and proximal to the expandable device. The system further may include non-transitory computer readable media having instructions stored thereon, wherein the instructions, when executed by a processor coupled to the sensors, cause the processor to estimate aortic blood flow based on the measured blood pressures and corresponding waveforms, compare the estimated aortic blood flow with a target aortic blood flow range, generate an alert if the estimated aortic blood flow falls outside the target aortic blood flow range, and cause the catheter controller unit to adjust expansion and contraction of the expandable device to adjust an amount of blood flow through the aorta if the estimated aortic blood flow falls outside the target aortic blood flow range.

A patient treatment system includes a ventilation bag, and a monitoring device which is configured so as to be connectable to the ventilation bag. The monitoring device measures the pulse rate derived from the heart rate of a neonate, from signals of ECG electrodes which are connected to the monitoring device. In a case where an abnormality of measurement information of the pulse rate is detected, the monitoring device notifies of first information prompting ventilation by the ventilation bag.

Various embodiments are described herein for a controller for controlling the operation of a breathing assistance device that provides breathing assistance to a user. The controller comprises a processor that generates a respiratory index value that is determined during a current monitoring time period to detect a respiratory failure, or predict the respiratory failure when at least one PSG signal is measured. The respiratory index value is compared to a threshold to determine if the control signal needs to be updated to reduce or eliminate respiratory failure that the user is currently experiencing or to prevent a predicted respiratory failure from occurring.

A relaxation mask includes: a main body that defines a pair of eye cavities; and a light diffuser. The light diffuser includes a first lens that is disposed within a first one of the eye cavities. A first ledge is disposed along a top edge of the first lens and extends outwardly therefrom. A first light emitting component is supported on the first ledge and is configured to fire downward into the first lens.